Marshall Wace, LLP Sab Biotherapeutics Inc Wt Exp Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Marshall Wace, LLP holds 247,576 shares of SABSW stock, worth $9,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247,576Holding current value
$9,903% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SABSW
# of Institutions
11Shares Held
879KCall Options Held
62.5KPut Options Held
0-
Lmr Partners LLP London, X0540KShares$21,5830.0% of portfolio
-
Morgan Stanley New York, NY146KShares$5,8570.0% of portfolio
-
Yakira Capital Management, Inc. Westport, CT93.2KShares$3,7290.0% of portfolio
-
Hb Wealth Management, LLC50KShares$2,0000.0% of portfolio
-
Walleye Trading LLC Plymouth, MN38.8KShares$1,5500.0% of portfolio
About SAB BIOTHERAPEUTICS INC WT EXP
- Ticker SABSW
- Sector Healthcare
- Industry Biotechnology